|
Market Closed -
Euronext Paris
01:55:00 11/09/26 am AEST
|
Pre-market 03:45:04 pm | |||
| 156.40 EUR | -1.32% |
|
156.60 | +0.13% |
| 08/09 | Rubis posts gold-standard results, telecom operators talk, Novartis has to pull the parachute. |  |
| 21/08 | Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- IPN Stock
- Consensus Ipsen
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
